Ibn Sina | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Monday
March 02, 2026

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
MONDAY, MARCH 02, 2026

Ibn Sina

Ibn Sina

Nagorik Coalition logo. Photo: Collected

Nagorik Coalition condemns Ibn Sina Pharma for ‘discriminatory’ male-only, Muslim-only job criteria

The coalition has urged Ibn Sina Pharmaceutical Industry to immediately withdraw the circular

IBN Sina Pharma posts 44% growth in profit during Jan-mar

IBN Sina Pharma posts 44% growth in profit during Jan-mar

Woman dies after C-section at Ibn Sina Hospital, family alleges negligence

Woman dies after C-section at Ibn Sina Hospital, family alleges negligence

IBN Sina Pharma declares highest cash dividend in 13 years

IBN Sina Pharma declares highest cash dividend in 13 years

IBN Sina’s profit grows 40% in Q1

IBN Sina’s profit grows 40% in Q1

IBN SINA Pharmaceuticals: Price Sensitive Information

IBN SINA Pharmaceuticals: Price Sensitive Information

Ibn Sina Pharmaceuticals: Price Sensitive Information

Ibn Sina Pharmaceuticals: Price Sensitive Information

Ibn Sina Pharmaceuticals: Price Sensitive Information

Ibn Sina Pharmaceuticals: Price Sensitive Information

IBN Sina Pharma to set up subsidiary in natural medicine business

IBN Sina Pharma to set up subsidiary in natural medicine business

IBN Sina Pharma recommends 38.5% cash dividend

IBN Sina Pharma recommends 38.5% cash dividend

Ibn Sina: Price Sensitive Information

Ibn Sina: Price Sensitive Information

The enduring legacy of Ibn Sina’s work on contagions

The enduring legacy of Ibn Sina’s work on contagions

The office of Ibn Sina Pharmaceuticals in Dhaka. Photo: Collected

IBN Sina Pharma to start food, plastic and API businesses

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2026
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net